Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

The 2007 WHO Classification of Tumours of the Central Nervous System

Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,422 · see citing works

Principal Component Analysis

Chiang, L. H., Russell, E. L., & Braatz, R. D. (2001) · Advanced textbooks in control and signal processing · doi:10.1007/978-1-4471-0347-9_4 · Cited by 6,684 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622 · see citing works

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · see citing works

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · cited 2× · see citing works

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Hartmann, C. J., Meyer, J., Balß, J., Capper, D., Mueller, W. C., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163 · see citing works

Glioma-Derived Mutations in <i>IDH1</i> Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119 · see citing works

Glucose Deprivation Contributes to the Development of <i>KRAS</i> Pathway Mutations in Tumor Cells

Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914 · see citing works

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736 · see citing works

Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism

Reitman, Z. J., & Yan, H. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq187 · Cited by 562 · see citing works

Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1

Seltzer, M. J., Bennett, B. D., Joshi, A. D., Gao, P., Thomas, A. G., Ferraris, D. V., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Rabinowitz, J. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1666 · Cited by 513 · see citing works

Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)

Fan, T. W. ‐., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H. T., Bousamra, M., & Miller, D. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-41 · Cited by 438 · see citing works

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

Jansen, M., Yip, S. S. F., & Louis, D. N. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70105-8 · Cited by 272 · see citing works

LC-MS-Based Metabolomics in Drug Metabolism

Chen, C., Gonzalez, F. J., & Idle, J. R. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701497804 · Cited by 261 · see citing works

Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death.

Griffin, J. L., Lehtimäki, K. K., Valonen, P. K., Gröhn, O. H. J., Kettunen, M. I., Ylä‐Herttuala, S., Pitkänen, A., Nicholson, J. K., & Kauppinen, R. A. (2003) · PubMed · Cited by 135 · see citing works

NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in d ‐2‐hydroxyglutaric aciduria

Kölker, S., Pawlak, V., Ahlemeyer, B., Okun, J. G., Hörster, F., Mayatepek, E., Krieglstein, J., Hoffmann, G. F., & Köhr, G. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02055.x · Cited by 133 · see citing works

2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations

Jin, G., Reitman, Z. J., Spasojevic, I., Batinic-Haberle, I., Yang, J., Schmidt-Kittler, O., Bigner, D. D., & Yan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016812 · Cited by 112 · see citing works

Pyruvate Kinase Type M2: A Key Regulator Within the Tumour Metabolome and a Tool for Metabolic Profiling of Tumours

Mazurek, S. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_091 · Cited by 76 · see citing works

Molecular Characterization of N-Acetylaspartylglutamate Synthetase

Becker, I., Lodder‐Gadaczek, J., Gieselmann, V., & Eckhardt, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111765 · Cited by 63 · see citing works

Evidence that the tri-cellular metabolism of N-acetylaspartate functions as the brain’s “operating system”: how NAA metabolism supports meaningful intercellular frequency-encoded communications

Baslow, M. H. (2010) · Amino Acids · doi:10.1007/s00726-010-0656-6 · Cited by 57 · see citing works

Molecular Identification of N-Acetylaspartylglutamate Synthase and β-Citrylglutamate Synthase

Collard, F., Stroobant, V., Lamosa, P., Kapanda, C. N., Lambert, D. M., Muccioli, G. G., Poupaert, J. H., Opperdoes, F. R., & SCHAFTINGEN, E. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152629 · Cited by 52 · see citing works

Stable isotope‐assisted metabolomics in cancer research

Lane, A. N., Fan, T. W. ‐., & Higashi, R. M. (2008) · IUBMB Life · doi:10.1002/iub.17 · Cited by 45 · see citing works

REPRESENTATION AND ANALYSIS OF MOLECULAR NETWORKS INVOLVING DISEASES AND DRUGS

Kanehisa, M. I. (2009) · doi:10.1142/9781848165632_0020 · Cited by 16 · see citing works

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation

Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,210 · see citing works

Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection

Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974 · see citing works

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789 · see citing works

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation

Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727 · see citing works

( <i>R</i> )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets

Han, S., Liu, Y., Cai, S. J., Qian, M., Ding, J., Larion, M., Gilbert, M. R., & Yang, C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0814-x · Cited by 661 · see citing works

Glioma

Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M. K., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 645 · see citing works

Emerging insights into the molecular and cellular basis of glioblastomaPreprint

Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 559 · see citing works

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate

Bunse, L., Pusch, S., Bunse, T., Sahm, F., Sanghvi, K., Friedrich, M., Alansary, D., Sonner, J. K., Green, E., Deumelandt, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0095-6 · Cited by 544 · see citing works

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1

Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., Pleier, S. V., Bai, A. H. C., Karra, D., Piro, R. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3217 · Cited by 486 · see citing works

Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities

Cairns, R. A., & Mak, T. W. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0083 · Cited by 452 · see citing works

Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion

Tateishi, K., Wakimoto, H., Iafrate, A. J., Tanaka, S., Loebel, F., Lelic, N., Wiederschain, D., Bedel, O., Deng, G., Zhang, B., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.006 · Cited by 433 · see citing works

Detection of 2-Hydroxyglutarate in <i>IDH</i> -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy

Andronesi, O. C., Kim, G. S., Gerstner, E., Batchelor, T., Tzika, A. A., Fantin, V. R., Vander Heiden, M. G., & Sorensen, A. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002693 · Cited by 438 · see citing works

Oncometabolites: linking altered metabolism with cancer

Yang, M. H., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 424 · see citing works

Coupling Krebs cycle metabolites to signalling in immunity and cancer

Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works

Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma

McBrayer, S. K., Mayers, J. R., DiNatale, G. J., Shi, D. D., Khanal, J., Chakraborty, A. A., Sarosiek, K. A., Briggs, K. J., Robbins, A. K., Sewastianik, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.038 · Cited by 368 · see citing works

Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis

Daye, D., & Wellen, K. E. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.002 · Cited by 375 · see citing works

Coordination of the transcriptome and metabolome by the circadian clock

Eckel‐Mahan, K. L., Patel, V. R., Mohney, R. P., Vignola, K. S., Baldi, P., & Sassone‐Corsi, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118726109 · Cited by 370 · see citing works

Altered cellular metabolism in gliomas — an emerging landscape of actionable co-dependency targets

Bi, J., Chowdhry, S., Wu, S., Zhang, W., Masui, K., & Mischel, P. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0226-5 · Cited by 348 · see citing works

Metabolism of [U‐ ¹³ C]glucose in human brain tumors <i>in vivo</i>

Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341 · see citing works

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

Pope, W. B., Prins, R. M., Albert Thomas, M., Nagarajan, R., Yen, K. E., Bittinger, M. A., Salamon, N., Chou, A. P., Yong, W. H., Soto, H., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0737-8 · Cited by 318 · see citing works

Role of mitochondrial dysfunction in cancer progression

Hsu, C., Tseng, L., & Lee, H. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216641787 · Cited by 306 · see citing works

IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism

Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280 · see citing works

Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway

Fu, Q., Liu, Y., Fan, Y., Hua, S., Hong-ying, Q., Dong, S.-W., Li, R.-L., Zhao, M., Zhen, Y., Yu, X., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0117-5 · Cited by 286 · see citing works

Isocitrate dehydrogenase mutations in gliomas

Waitkus, M. S., Diplas, B. H., & Yan, H. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov136 · Cited by 282 · see citing works

Metabolomic markers reveal novel pathways of ageing and early development in human populations

Menni, C., Kastenmüller, G., Petersen, A. K., Bell, J. T., Psatha, M., Tsai, P.-C., Gieger, C., Schulz, H., Erte, I., John, S., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt094 · Cited by 282 · see citing works

Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms

Sotgia, F., Martinez‐Outschoorn, U., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 283 · see citing works

Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition

Boudreau, A., Purkey, H. E., Hitz, A., Robarge, K., Peterson, D., Labadie, S., Kwong, M., Hong, R., Gao, M., Del Nagro, C., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2143 · Cited by 280 · see citing works

Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy

Tan, Z., Xiao, L., Tang, M., Bai, F., Li, J., Li, L., Shi, F., Li, N., Li, Y., Du, Q., et al. (2018) · Theranostics · doi:10.7150/thno.21451 · Cited by 272 · see citing works

Revisiting the TCA cycle: signaling to tumor formation

Raimundo, N., Baysal, B. E., & Shadel, G. S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.001 · Cited by 271 · see citing works

Oxidative Stress and Metabolic Perturbations in Wooden Breast Disorder in Chickens

Abasht, B., Mutryn, M. F., Michalek, R. D., & Lee, W. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153750 · Cited by 258 · see citing works

Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours

Missiroli, S., Perrone, M., Genovese, I., Pinton, P., & Giorgi, C. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102943 · Cited by 258 · see citing works

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

Miller, J. J., Castro, L. N. G., McBrayer, S. K., Weller, M., Cloughesy, T. F., Portnow, J., Andronesi, O. C., Barnholtz‐Sloan, J. S., Baumert, B. G., Berger, M. S., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac207 · Cited by 253 · see citing works

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma

Kipp, B. R., Voss, J. S., Kerr, S. E., Fritcher, E. G. B., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 243 · see citing works

Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease

James, E. L., Michalek, R. D., Pitiyage, G. N., de Castro, A. M., Vignola, K. S., Jones, J., Mohney, R. P., Karoly, E. D., Prime, S. S., & Parkinson, E. K. (2015) · Journal of Proteome Research · doi:10.1021/pr501221g · Cited by 231 · see citing works

Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates

Ye, D., Guan, K.-L., & Xiong, Y. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2017.12.005 · Cited by 242 · see citing works

Spectrum of somatic mitochondrial mutations in five cancers

Larman, T., DePalma, S. R., Hadjipanayis, A. G., Protopopov, A. I., Zhang, J., Gabriel, S., Chin, L., Seidman, C. E., Kucherlapati, R., & Seidman, J. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211502109 · Cited by 238 · see citing works

2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling

Fu, X., Chin, R., Vergnes, L., Hwang, H., Deng, G., Xing, Y., Pai, M. Y., Li, S., Ta, L. H., Fazlollahi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.009 · Cited by 230 · see citing works

Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas

Friedrich, M., Sankowski, R., Bunse, L., Kilian, M., Green, E., Guevara, C. R., Pusch, S., Poschet, G., Sanghvi, K., Hahn, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00201-z · Cited by 232 · see citing works

IDH Mutation in Glioma

Turkalp, Z. T., Karamchandani, J., & Das, S. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1205 · Cited by 222 · see citing works

Stable isotope-resolved metabolomics and applications for drug development

Fan, T. W. ‐., Lorkiewicz, P. K., Sellers, K., Moseley, H., Higashi, R. M., & Lane, A. N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.007 · Cited by 209 · see citing works

Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer

Clark, O., Yen, K. E., & Mellinghoff, I. K. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1333 · Cited by 205 · see citing works

Key Electrophysiological, Molecular, and Metabolic Signatures of Sleep and Wakefulness Revealed in Primary Cortical Cultures

Hinard, V., Mikhail, C., Pradervand, S., Curie, T., Houtkooper, R. H., Auwerx, J. H., Franken, P., & Tafti, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2306-12.2012 · Cited by 202 · see citing works

Isocitrate Dehydrogenase Mutation and ( <i>R</i> )-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development

Dang, L., & Su, S.-S. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044732 · Cited by 204 · see citing works

A Gradient of Glycolytic Activity Coordinates FGF and Wnt Signaling during Elongation of the Body Axis in Amniote Embryos

Oginuma, M., Moncuquet, P., Xiong, F., Karoly, E. D., Chal, J., Guevorkian, K., & Pourquié, O. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.02.001 · Cited by 202 · see citing works

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy

Xiao, L., Hu, Z., Dong, X., Tan, Z. W., Li, W., Tang, M., Chen, L., Yang, L., Tao, Y., Jiang, Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.32 · Cited by 197 · see citing works

An in vivo patient-derived model of endogenous IDH1-mutant glioma

Luchman, H. A., Stechishin, O. D. M., Dang, N. H., Blough, M. D., Chesnelong, C., Kelly, J. J., Nguyen, S. A., Chan, J. A.-W., Weljie, A. M., Cairncross, J. G., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor207 · Cited by 194 · see citing works

A joint analysis of metabolomics and genetics of breast cancer

Tang, X., Lin, C., Spasojević, I., Iversen, E. S., Chi, J., & Marks, J. R. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0415-9 · Cited by 197 · see citing works

Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy

Drake, J. C., Wilson, R. J., Laker, R. C., Guan, Y., Spaulding, H. R., Nichenko, A. S., Shen, W., Shang, H., Dorn, M. V., Huang, K. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025932118 · Cited by 196 · see citing works

Metabolic symbiosis in cancer: Refocusing the Warburg lens

Nakajima, E. C., & Houten, B. V. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21863 · Cited by 176 · see citing works

A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylationPreprint

Duncan, C. G., Barwick, B. G., Jin, G., Rago, C., Kapoor-Vazirani, P., Powell, D. R., Chi, J., Bigner, D. D., Vertino, P. M., & Yan, H. (2012) · Genome Research · doi:10.1101/gr.132738.111 · Cited by 176 · see citing works

Elevated CO2 Levels Cause Mitochondrial Dysfunction and Impair Cell Proliferation

Vohwinkel, C. U., Lecuona, E., Sun, H., Sommer, N., Vadász, I., Chandel, N. S., & Sznajder, J. I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290056 · Cited by 173 · see citing works

Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate

Andronesi, O. C., Rapalino, O., Gerstner, E. R., Chi, A. S., Batchelor, T. T., Cahill, D. P., Sorensen, A. G., & Rosen, B. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67229 · Cited by 174 · see citing works

Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI

Jiang, S., Zou, T., Eberhart, C. G., Villalobos, M. A. V., Heo, H., Zhang, Y., Wang, Y., Wang, X., Yu, H., Du, Y., et al. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26820 · Cited by 172 · see citing works

Cancer Metabolism and Drug Resistance

Rahman, M., & Hasan, M. R. (2015) · Metabolites · doi:10.3390/metabo5040571 · Cited by 168 · see citing works

The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism

Chinnaiyan, P., Kensicki, E., Bloom, G. C., Prabhu, A. H., Sarcar, B., Kahali, S., Eschrich, S. A., Qu, X., Forsyth, P. A., & Gillies, R. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1572-t · Cited by 168 · see citing works

PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype

Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L., Li, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10068 · Cited by 169 · see citing works

What do we know about IDH1/2 mutations so far, and how do we use it?

Horbinski, C. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1106-9 · Cited by 163 · see citing works

Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome

Chumpitazi, B. P., Hollister, E. B., Oezguen, N., Tsai, C. M., McMeans, A. R., Luna, R. A., Savidge, T. C., Versalovic, J., & Shulman, R. J. (2014) · Gut Microbes · doi:10.4161/gmic.27923 · Cited by 156 · see citing works

Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma

Bhatt, A. P., Jacobs, S. R., Freemerman, A. J., Makowski, L., Rathmell, J. C., Dittmer, D. P., & Damania, B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205995109 · Cited by 163 · see citing works

Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation

Leonardi, R., Subramanian, C., Jackowski, S., & Rock, C. O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.353946 · Cited by 165 · see citing works

TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State

Cardaci, S., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/161837 · Cited by 162 · see citing works

Oncogene-induced senescence results in marked metabolic and bioenergetic alterations

Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155 · see citing works

Landscape of the mitochondrial Hsp90 metabolome in tumours

Chae, Y. C., Angelin, A., Lisanti, S., Kossenkov, A. V., Speicher, K. D., Wang, H., Powers, J. F., Tischler, A. S., Pacák, K., Fliedner, S. M. J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3139 · Cited by 158 · see citing works

Metabolic consequences of oncogenic IDH mutations

Parker, S. J., & Metallo, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.003 · Cited by 158 · see citing works

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma

Gamble, L. D., Purgato, S., Murray, J. E., Xiao, L., Yu, D. M. T., Hanssen, K. M., Giorgi, F. M., Carter, D. R., Gifford, A. J., Valli, E., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1099 · Cited by 155 · see citing works

The Roles of 2-Hydroxyglutarate

Du, X., & Hu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651317 · Cited by 152 · see citing works

Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate

Andronesi, O. C., Loebel, F., Bogner, W., Marjańska, M., Heiden, M. G. V., Iafrate, A. J., Dietrich, J., Batchelor, T. T., Gerstner, E. R., Kaelin, W. G., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0656 · Cited by 153 · see citing works

Targeting cancer metabolism

Teicher, B. A., Linehan, W. M., & Helman, L. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2587 · Cited by 152 · see citing works

IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom

Stockhammer, F., Misch, M., Helms, H., Lengler, U., Prall, F., von Deimling, A., & Hartmann, C. J. (2012) · Seizure · doi:10.1016/j.seizure.2011.12.007 · Cited by 147 · see citing works

Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways

Fack, F., Tardito, S., Hochart, G., Oudin, A., Zheng, L., Fritah, S., Golebiewska, A., Nazarov, P. V., Bernard, A., Hau, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707729 · Cited by 144 · see citing works

Oncometabolites: tailoring our genes

Nowicki, S., & Gottlieb, E. (2015) · FEBS Journal · doi:10.1111/febs.13295 · Cited by 145 · see citing works

Inhaled ozone (O3)-induces changes in serum metabolomic and liver transcriptomic profiles in rats

Miller, D. B., Karoly, E. D., Jones, J. C., Ward, W. O., Vallanat, B., Andrews, D. L., Schladweiler, M. C. J., Snow, S. J., Bass, V. L., Richards, J. H., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.025 · Cited by 143 · see citing works

Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling

Gagné, L. M., Boulay, K., Topisirović, I., Huot, M., & Mallette, F. A. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.002 · Cited by 141 · see citing works

Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic Reprogramming

Fessel, J. P., Hamid, R., Wittmann, B. M., Robinson, L. J., Blackwell, T., Tada, Y., Tanabe, N., Tatsumi, K., Hemnes, A. R., & West, J. D. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.97606 · Cited by 138 · see citing works

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer

Schuler, K., Rambally, B. S., DiFurio, M. J., Sampey, B. P., Gehrig, P. A., Makowski, L., & Bae-Jump, V. L. (2014) · Cancer Medicine · doi:10.1002/cam4.353 · Cited by 136 · see citing works

Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells

Sun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D. P., WILSON, C. A., Zhuang, G., Gao, M., Liu, P. J., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 134 · see citing works

Lower Grade Gliomas

Youssef, G., & Miller, J. J. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01040-8 · Cited by 140 · see citing works

Biological insights through nontargeted metabolomics

Sévin, D. C., Kuehne, A., Zamboni, N., & Sauer, U. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.001 · Cited by 134 · see citing works

IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma

Zhang, C., Moore, L. M., Li, X., Yung, W. K. A., & Zhang, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not087 · Cited by 132 · see citing works

Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer

Benjamin, D. I., Cravatt, B. F., & Nomura, D. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.013 · Cited by 130 · see citing works

The Secreted Protein ANGPTL2 Promotes Metastasis of Osteosarcoma Cells Through Integrin α 5 β 1 , p38 MAPK, and Matrix Metalloproteinases

Odagiri, H., Kadomatsu, T., Endo, M., Masuda, T., Morioka, M. S., Fukuhara, S., Miyamoto, T. K., Kobayashi, E., Miyata, K., Aoi, J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004612 · Cited by 127 · see citing works

Disruption of Wild-Type IDH1 Suppresses D-2-Hydroxyglutarate Production in IDH1-Mutated Gliomas

Jin, G., Reitman, Z. J., Duncan, C. G., Spasojević, I., Gooden, D. M., Rasheed, B. A., Yang, R. R., Lopez, G. Y., He, Y., McLendon, R. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2852 · Cited by 124 · see citing works

Caveolin-1 Is a Critical Determinant of Autophagy, Metabolic Switching, and Oxidative Stress in Vascular Endothelium

Shiroto, T., Romero, N., Sugiyama, T., Sartoretto, J. L., Kalwa, H., Yan, Z., Shimokawa, H., & Michel, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087871 · Cited by 125 · see citing works

<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism

Izquierdo-Garcia, J. L., Viswanath, P., Eriksson, P., Cai, L., Radoul, M., Chaumeil, M. M., Blough, M., Luchman, H. A., Weiss, S., Cairncross, J. G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0840 · Cited by 123 · see citing works

Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation

Ohka, F., Ito, M., Ranjit, M., Senga, T., Motomura, A., Motomura, K., Saito, K., Kato, K., Kato, Y., Wakabayashi, T., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1784-5 · Cited by 121 · see citing works

Mitochondrial dysfunctions in cancer: Genetic defects and oncogenic signaling impinging on TCA cycle activity

Desideri, E., Vegliante, R., & Ciriolo, M. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.023 · Cited by 113 · see citing works

Profiling metabolic networks to study cancer metabolism

Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 111 · see citing works

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins

Kaminska, B., Czapski, B., Guzik, R., Król, S. K., & Gielniewski, B. (2019) · Molecules · doi:10.3390/molecules24050968 · Cited by 110 · see citing works

In Vivo Imaging of Glutamine Metabolism to the Oncometabolite 2-Hydroxyglutarate in IDH1/2 Mutant Tumors

Salamanca-Cardona, L., Shah, H., Poot, A. J., Correa, F. M., Di Gialleonardo, V., Lui, H., Miloushev, V. Z., Granlund, K. L., Tee, S. S., Cross, J. R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.001 · Cited by 106 · see citing works

Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells

Kucharzewska, P., Christianson, H. C., & Belting, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116740 · Cited by 106 · see citing works

Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapies

Masui, K., Cloughesy, T. F., & Mischel, P. S. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01238.x · Cited by 107 · see citing works

The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells

Smolková, K., & Ježek, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/273947 · Cited by 108 · see citing works

Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations

Kerr, D. A., Lopez, H. U., Deshpande, V., Hornicek, F. J., Duan, Z., Zhang, Y., Rosenberg, A. E., Borger, D. R., & Nielsen, G. P. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31827ab703 · Cited by 105 · see citing works

GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients

Nakamizo, S., Sasayama, T., Shinohara, M., Irino, Y., Nishiumi, S., Nishihara, M., Tanaka, H., Tanaka, K., Mizukawa, K., Itoh, T., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1090-x · Cited by 101 · see citing works

Genomic and Metabolic Responses to Methionine-Restricted and Methionine-Restricted, Cysteine-Supplemented Diets in Fischer 344 Rat Inguinal Adipose Tissue, Liver and Quadriceps Muscle

Perrone, C. E., Mattocks, D. A. L., Plummer, J. D., Chittur, S. V., Mohney, R. P., Vignola, K. S., Orentreich, D. S., & Orentreich∥, N. (2012) · Lifestyle Genomics · doi:10.1159/000339347 · Cited by 100 · see citing works

Applications of metabolomics in cancer research

Styczynski, M. P., & Vermeersch, K. A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.113622 · Cited by 100 · see citing works

The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1 -Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity

Tateishi, K., Higuchi, F., Miller, J. J., Koerner, M. V. A., Lelic, N., Shankar, G. M., Tanaka, S., Fisher, D. E., Batchelor, T. T., Iafrate, A. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2263 · Cited by 98 · see citing works

Biochemical alterations associated with ALS

Lawton, K. A., Cudkowicz, M., Brown, M. V., Alexander, D. C., Caffrey, R., Wulff, J. E., Bowser, R. P., Lawson, R. J., Jaffa, M., Milburn, M. V., et al. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.619197 · Cited by 92 · see citing works

Integrated metabolomic and transcriptome analyses reveal finishing forage affects metabolic pathways related to beef quality and animal welfare

Carrillo, J. A., He, Y., Li, Y., Liu, J., Erdman, R. A., Sonstegard, T. S., & Song, J. (2016) · Scientific Reports · doi:10.1038/srep25948 · Cited by 92 · see citing works

Abstract LB-257: Profiling the effects of IDH1 and IDH2 mutants on the glioma cell metabolome

Yan, H., Reitman, Z. J., Jin, G., Spasojević, I., He, Y., Bigner, D. D., Karoly, E. D., Yang, J. P., Kinzler, K. W., & Vogelstein, B. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-lb-257

Exploring metabolic vulnerability and therapeutic potential in cancers with isocitrate dehydrogenase mutations

Hvinden, I. C. (2022) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-g2zdznr21

Biochemical Characterization and Genetic Modeling of Glioma-Associated Mutations in Isocitrate Dehydrogenases.

Lopez, G. Y. (2014) · DukeSpace (Duke University)

Metabolism of glioma and IDH1/IDH2 mutations

Rossetto, M., Ciccarino, P., Boisselier, B., Labussière, M., & Sanson, M. (2011) · Revue Neurologique · doi:10.1016/j.neurol.2011.08.002 · Cited by 14 · see citing works

Genetic Dissection of the Biological and Molecular Role of IDH1 Mutations in Glioma

Reitman, Z. J. (2012) · DukeSpace (Duke University)